Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Army
Accenture
Teva
Fish and Richardson
Citi
Healthtrust
Federal Trade Commission
Cantor Fitzgerald

Generated: April 19, 2018

DrugPatentWatch Database Preview

Abbvie Endocrine Company Profile

« Back to Dashboard

What is the competitive landscape for ABBVIE ENDOCRINE, and what generic alternatives to ABBVIE ENDOCRINE drugs are available?

ABBVIE ENDOCRINE has seven approved drugs.

There are three US patents protecting ABBVIE ENDOCRINE drugs.

There are ninety-four patent family members on ABBVIE ENDOCRINE drugs in forty-one countries.

Summary for Abbvie Endocrine
International Patents:94
US Patents:3
Tradenames:4
Ingredients:2
NDAs:7

Drugs and US Patents for Abbvie Endocrine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie Endocrine Inc LUPRON DEPOT leuprolide acetate INJECTABLE;INJECTION 020517-001 Dec 22, 1995 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie Endocrine LUPANETA PACK leuprolide acetate; norethindrone acetate INJECTABLE, TABLET;INTRAMUSCULAR, ORAL 203696-001 Dec 14, 2012 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie Endocrine Inc LUPRON DEPOT-PED leuprolide acetate INJECTABLE;INJECTION 020263-002 Apr 16, 1993 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie Endocrine Inc LUPRON DEPOT leuprolide acetate INJECTABLE;INJECTION 020708-001 Mar 7, 1997 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Abbvie Endocrine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie Endocrine Inc LUPRON DEPOT leuprolide acetate INJECTABLE;INJECTION 020517-001 Dec 22, 1995 4,728,721 ➤ Try a Free Trial
Abbvie Endocrine Inc LUPRON DEPOT-PED leuprolide acetate INJECTABLE;INJECTION 020263-004 Apr 16, 1993 4,917,893 ➤ Try a Free Trial
Abbvie Endocrine Inc LUPRON leuprolide acetate INJECTABLE;INJECTION 019010-001 Apr 9, 1985 4,005,063 ➤ Try a Free Trial
Abbvie Endocrine Inc LUPRON DEPOT leuprolide acetate INJECTABLE;INJECTION 020708-001 Mar 7, 1997 5,814,342 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Abbvie Endocrine

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,617,303 Sustained-release composition and method for producing the same ➤ Try a Free Trial
8,067,030 Controlled release composition and method of producing the same ➤ Try a Free Trial
9,713,595 Sustained-release composition and method for producing the same ➤ Try a Free Trial
8,246,987 Controlled release composition and method of producing the same ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Chubb
Dow
Accenture
Baxter
QuintilesIMS
Moodys
US Department of Justice
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.